BLCM Annual Operating Profit
-$26.98 M
-$2.59 M-10.63%
31 December 2022
Summary:
As of February 5, 2025, BLCM annual operaing income is -$26.98 million, with the most recent change of -$2.59 million (-10.63%) on December 31, 2022. During the last 3 years, it has risen by +$60.38 million (+69.12%).BLCM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM Quarterly Operating Profit
-$774.00 K
+$6.29 M+89.05%
01 September 2023
Summary:
As of February 5, 2025, BLCM quarterly operating income is -$774.00 thousand, with the most recent change of +$6.29 million (+89.05%) on September 1, 2023. Over the past year, it has increased by +$6.39 million (+89.20%).BLCM Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM TTM Operating Profit
-$23.83 M
+$6.39 M+21.15%
01 September 2023
Summary:
As of February 5, 2025, BLCM TTM operating income is -$23.83 million, with the most recent change of +$6.39 million (+21.15%) on September 1, 2023. Over the past year, it has increased by +$914.00 thousand (+3.69%).BLCM TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.6% | +89.2% | +3.7% |
| 3 y3 years | +69.1% | +93.7% | +57.7% |
| 5 y5 years | +69.1% | +96.7% | +72.7% |
BLCM Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +330.4% | at high | +859.7% |
Bellicum Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$774.00 K(-89.0%) | -$23.83 M(-21.2%) |
| June 2023 | - | -$7.07 M(-18.3%) | -$30.22 M(+1.8%) |
| Mar 2023 | - | -$8.64 M(+17.8%) | -$29.69 M(+10.0%) |
| Dec 2022 | -$26.98 M(+10.6%) | -$7.34 M(+2.4%) | -$26.98 M(+9.1%) |
| Sept 2022 | - | -$7.17 M(+9.6%) | -$24.74 M(+20.1%) |
| June 2022 | - | -$6.54 M(+10.1%) | -$20.60 M(-5.7%) |
| Mar 2022 | - | -$5.94 M(+16.5%) | -$21.85 M(-10.4%) |
| Dec 2021 | -$24.39 M(-54.9%) | -$5.10 M(+68.3%) | -$24.39 M(-21.2%) |
| Sept 2021 | - | -$3.03 M(-61.1%) | -$30.93 M(-23.1%) |
| June 2021 | - | -$7.79 M(-8.1%) | -$40.20 M(-16.1%) |
| Mar 2021 | - | -$8.47 M(-27.2%) | -$47.94 M(-11.4%) |
| Dec 2020 | -$54.08 M(-38.1%) | -$11.64 M(-5.4%) | -$54.08 M(-4.0%) |
| Sept 2020 | - | -$12.30 M(-20.7%) | -$56.34 M(-16.5%) |
| June 2020 | - | -$15.52 M(+6.2%) | -$67.47 M(-13.6%) |
| Mar 2020 | - | -$14.62 M(+5.2%) | -$78.11 M(-10.6%) |
| Dec 2019 | -$87.36 M(-8.5%) | -$13.90 M(-40.7%) | -$87.36 M(-12.7%) |
| Sept 2019 | - | -$23.44 M(-10.4%) | -$100.03 M(+0.2%) |
| June 2019 | - | -$26.16 M(+9.6%) | -$99.82 M(+2.7%) |
| Mar 2019 | - | -$23.87 M(-10.2%) | -$97.23 M(+1.8%) |
| Dec 2018 | -$95.47 M | -$26.57 M(+14.4%) | -$95.47 M(+8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$23.23 M(-1.4%) | -$88.34 M(+0.6%) |
| June 2018 | - | -$23.57 M(+6.6%) | -$87.82 M(-0.3%) |
| Mar 2018 | - | -$22.10 M(+13.7%) | -$88.04 M(+0.7%) |
| Dec 2017 | -$87.39 M(+27.8%) | -$19.45 M(-14.4%) | -$87.39 M(-0.1%) |
| Sept 2017 | - | -$22.70 M(-4.6%) | -$87.45 M(+6.4%) |
| June 2017 | - | -$23.79 M(+10.9%) | -$82.18 M(+10.1%) |
| Mar 2017 | - | -$21.45 M(+9.9%) | -$74.65 M(+9.2%) |
| Dec 2016 | -$68.38 M(+39.2%) | -$19.51 M(+12.0%) | -$68.38 M(+3.8%) |
| Sept 2016 | - | -$17.43 M(+7.2%) | -$65.87 M(+6.1%) |
| June 2016 | - | -$16.26 M(+7.1%) | -$62.06 M(+9.8%) |
| Mar 2016 | - | -$15.18 M(-10.7%) | -$56.51 M(+15.0%) |
| Dec 2015 | -$49.13 M(+235.9%) | -$17.00 M(+24.9%) | -$49.13 M(+28.3%) |
| Sept 2015 | - | -$13.62 M(+27.2%) | -$38.31 M(+38.9%) |
| June 2015 | - | -$10.71 M(+37.1%) | -$27.59 M(+36.9%) |
| Mar 2015 | - | -$7.81 M(+26.4%) | -$20.16 M(+37.8%) |
| Dec 2014 | -$14.63 M(+84.6%) | -$6.18 M(+113.3%) | -$14.63 M(+33.8%) |
| Sept 2014 | - | -$2.90 M(-11.5%) | -$10.93 M(+36.1%) |
| June 2014 | - | -$3.27 M(+43.7%) | -$8.03 M(+68.8%) |
| Mar 2014 | - | -$2.28 M(-8.3%) | -$4.76 M(+91.7%) |
| Dec 2013 | -$7.92 M(+26.4%) | -$2.48 M | -$2.48 M |
| Dec 2012 | -$6.27 M | - | - |
FAQ
- What is Bellicum Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals annual operating profit year-on-year change?
- What is Bellicum Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals quarterly operating profit year-on-year change?
- What is Bellicum Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals TTM operating profit year-on-year change?
What is Bellicum Pharmaceuticals annual operaing income?
The current annual operating profit of BLCM is -$26.98 M
What is the all time high annual operating profit for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high annual operaing income is -$6.27 M
What is Bellicum Pharmaceuticals annual operating profit year-on-year change?
Over the past year, BLCM annual operaing income has changed by -$2.59 M (-10.63%)
What is Bellicum Pharmaceuticals quarterly operating income?
The current quarterly operating profit of BLCM is -$774.00 K
What is the all time high quarterly operating profit for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high quarterly operating income is -$774.00 K
What is Bellicum Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, BLCM quarterly operating income has changed by +$6.39 M (+89.20%)
What is Bellicum Pharmaceuticals TTM operating income?
The current TTM operating profit of BLCM is -$23.83 M
What is the all time high TTM operating profit for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high TTM operating income is -$2.48 M
What is Bellicum Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, BLCM TTM operating income has changed by +$914.00 K (+3.69%)